• Obama's Healthcare Law Paves the Pathway for Approval of Biosimilar Drugs
  • April 15, 2010
  • Law Firm: Kaye Scholer LLP - New York Office
  • The Patient Protection and Affordable Care Act was signed into law by President Obama on March 23, 2010 (as Pub. L. No. 111-148). With it come some important changes for the biotechnology industry, particularly as contained in a subtitle known as the Biologics Price Competition and Innovation Act of 2009.